These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6126762)

  • 41. The health of atomic bomb survivors: a decade of examinations in a fixed population.
    Belsky JL; Tachikawa K; Jablon S
    Yale J Biol Med; 1973 Oct; 46(4):284-96. PubMed ID: 4775684
    [No Abstract]   [Full Text] [Related]  

  • 42. Genetics. DNA mutations linked to Soviet bomb tests.
    Stone R
    Science; 2002 Feb; 295(5557):946. PubMed ID: 11834788
    [No Abstract]   [Full Text] [Related]  

  • 43. [Dose-effect relationships in Hiroshima and Nagasaki and the evaluation of radiation risks taking into account the fallout dose].
    Schmitz-Feuerhake I; Carbonell P; Wellner R
    Strahlenschutz Forsch Prax; 1985; 25():229-37. PubMed ID: 21452582
    [No Abstract]   [Full Text] [Related]  

  • 44. Testicular changes in atomic bomb survivors.
    Jordan SW; Hasegawa CM; Keehn RJ
    Arch Pathol; 1966 Dec; 82(6):542-54. PubMed ID: 5922670
    [No Abstract]   [Full Text] [Related]  

  • 45. [Late sequelae following atomic bomb explosions and radiation accidents].
    Fischer H
    MMW Munch Med Wochenschr; 1975 Nov; 117(47):1893-8. PubMed ID: 813116
    [No Abstract]   [Full Text] [Related]  

  • 46. Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl.
    Boice JD
    JAMA; 2006 Mar; 295(9):1060-2. PubMed ID: 16507808
    [No Abstract]   [Full Text] [Related]  

  • 47. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.
    Imaizumi M; Usa T; Tominaga T; Neriishi K; Akahoshi M; Nakashima E; Ashizawa K; Hida A; Soda M; Fujiwara S; Yamada M; Ejima E; Yokoyama N; Okubo M; Sugino K; Suzuki G; Maeda R; Nagataki S; Eguchi K
    JAMA; 2006 Mar; 295(9):1011-22. PubMed ID: 16507802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The low-level nuclear threat.
    Nature; 2012 Feb; 482(7383):5. PubMed ID: 22297929
    [No Abstract]   [Full Text] [Related]  

  • 49. [Radioactive fallout and thyroid cancer in Norway].
    Lund E; Oftedal P
    Tidsskr Nor Laegeforen; 1986 Aug; 106(22):1680-2. PubMed ID: 3775698
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors.
    Neriishi K; Akiba S; Amano T; Ogino T; Kodama K
    Radiat Res; 1995 Nov; 144(2):215-21. PubMed ID: 7480648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Biological effects and mortality in connection with low dosage ionizing radiation].
    Henriksen JH
    Ugeskr Laeger; 2001 Jan; 163(1):44-5. PubMed ID: 11586674
    [No Abstract]   [Full Text] [Related]  

  • 52. Fallout in the hypocenter area of the Hiroshima atomic bomb.
    Shizuma K; Iwatani K; Hasai H; Hoshi M
    Health Phys; 1989 Dec; 57(6):1013-6. PubMed ID: 2584016
    [No Abstract]   [Full Text] [Related]  

  • 53. Exposure to an atomic bomb explosion is a risk factor for in-hospital death after esophagectomy to treat esophageal cancer.
    Nakashima Y; Takeishi K; Guntani A; Tsujita E; Yoshinaga K; Matsuyama A; Hamatake M; Maeda T; Tsutsui S; Matsuda H; Ishida T
    Dis Esophagus; 2015 Jan; 28(1):78-83. PubMed ID: 24224952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-cancer diseases of Korean atomic bomb survivors in residence at Hapcheon, Republic of Korea.
    Ju YS; Jhun HJ; Kim JB; Kim JK
    J Korean Med Sci; 2006 Jun; 21(3):385-90. PubMed ID: 16778377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Radioactive fallout after reactor accidents and nuclear weapons testing].
    Lote K; Klepp O; Reitan JB
    Tidsskr Nor Laegeforen; 1986 Aug; 106(23):1836-40. PubMed ID: 3764861
    [No Abstract]   [Full Text] [Related]  

  • 56. Let us come back to 'radiation hormesis'.
    Delpla M
    Health Phys; 1989 Jul; 57(1):203-4. PubMed ID: 2745085
    [No Abstract]   [Full Text] [Related]  

  • 57. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
    World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950--30 September 1966.
    Ishimaru T; Hoshino T; Ichimaru M; Okada H; Tomiyasu T
    Radiat Res; 1971 Jan; 45(1):216-33. PubMed ID: 5275936
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies of the mortality of A-bomb survivors. 7. Mortality, 1950-1978: Part I. Cancer mortality.
    Kato H; Schull WJ
    Radiat Res; 1982 May; 90(2):395-432. PubMed ID: 7079470
    [No Abstract]   [Full Text] [Related]  

  • 60. Comment to Dr. Delpla's 'Let Us Come Back to Radiation Hormesis.
    Kato H
    Health Phys; 1989 Jul; 57(1):205. PubMed ID: 2745086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.